Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/08/2008EP1978031A2 Tropoelastin derivatives
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1978025A1 Novel kappa receptor selective opioid peptides
10/08/2008EP1978021A1 Novel antibiotics
10/08/2008EP1978020A1 Processes for the preparation of statins, particularly rosuvastatin, and intermediates for the preparation thereof
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1978016A1 Asymmetric reduction method
10/08/2008EP1977773A1 Ameliorating agent for aluminum storage disease
10/08/2008EP1977766A1 Drug delivery material
10/08/2008EP1977762A1 Ctgf as target for the therapy of diabetic nephropathy
10/08/2008EP1977760A2 Method for Treating Cervical Cancer
10/08/2008EP1977759A1 Pharmaceutical composition comprising a cytokine
10/08/2008EP1977753A1 Combined preparation comprising anthracycline derivatives
10/08/2008EP1977752A1 Pharmaceutical composition for reducing endometriosis
10/08/2008EP1977751A1 Use of crystalline (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole for manufacturing pharmaceutical compositions
10/08/2008EP1977750A1 Use of thioproline in body weight reduction treatments
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1977748A1 Compounds having neuroprotective properties
10/08/2008EP1977747A1 Adaptive cardiac remodeling by beta-catenin downregulation
10/08/2008EP1977746A1 Methods and compositions for reduction of side effects of therapeutic treatments
10/08/2008EP1977745A1 Method for the treatment of incontinence
10/08/2008EP1977744A1 Polymorphic Form alpha of (S)-Pregabalin and process for its preparation
10/08/2008EP1977743A1 Compositions containing retinoid and beta-aminoisobutyic acid derivates
10/08/2008EP1977742A1 Preventive/remedy for urinary calculosis
10/08/2008EP1977741A2 Use of renin inhibitors in therapy
10/08/2008EP1977740A1 Composition comprising formoterol and a glucocorticosteroid
10/08/2008EP1977739A1 Nanoparticulate composition of chitosan and chondroitin sulfate
10/08/2008EP1977738A1 Pharmaceutical compositions comprising atorvastatin manufactured without granulation
10/08/2008EP1977736A1 Oral pulsed dose drug delivery system
10/08/2008EP1977735A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders
10/08/2008EP1977734A1 A method of producing fast dissolving tablets
10/08/2008EP1977643A1 Manufacture of a viable, storable worm egg suspension
10/08/2008EP1977249A2 Method of diagnosis and method of treatment
10/08/2008EP1977246A1 Na+, k+-atpase expression in cervical dysplasia and cancer
10/08/2008EP1976974A2 Pneumococcal serotypes
10/08/2008EP1976870A1 Prevention/treatment of ichthyosis vulgaris, atopy and other disorders
10/08/2008EP1976859A1 CRYSTALLINE FORM OF 1´-(1-METHYLETHYL)- 4´-[(2-FLUORO-4-METHOXYPHENYL)METHYL]-5´-METHYL-1H-PYRAZOL-3´-O-beta-D-GLUCOPYRANOSIDE, A METHOD FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
10/08/2008EP1976858A2 Method for preparing 4-demethyldaunorubicin
10/08/2008EP1976853A1 Novel compounds and use thereof
10/08/2008EP1976851A2 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976848A2 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/08/2008EP1976847A2 Pyrimidinyl aryl urea derivatives being fgf inhibitors
10/08/2008EP1976841A1 Heterocyclic amide derivatives as calcium channel blockers
10/08/2008EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976837A1 Dicarbonylic compounds with antibacterial activity
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976834A2 Heterocycle substituted ketone derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976833A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976829A2 N-(6-membered aromatic ring)-amido anti-viral compounds
10/08/2008EP1976828A1 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
10/08/2008EP1976823A1 Dibenzene derivatives as calcium channel blockers
10/08/2008EP1976818A2 Chalcone derivatives with antimitotic activity
10/08/2008EP1976595A2 The use of memantine and brimonidine to attenuate vitreoretinal vascular endothelial growth factor (vegf) protein levels in animals
10/08/2008EP1976566A2 Compositions and methods for altering rnai
10/08/2008EP1976561A2 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type
10/08/2008EP1976551A2 Compositions comprising polycation-complexed protein crystals and methods of treatment using them
10/08/2008EP1976549A2 Endothelin receptors in morphine withdrawal
10/08/2008EP1976539A2 Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents
10/08/2008EP1976538A1 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid
10/08/2008EP1976537A1 Hemostatic material
10/08/2008EP1976536A2 Boron-containing small molecules
10/08/2008EP1976535A2 Treatment of acute respiratory distress syndrome
10/08/2008EP1976534A1 Sterilized nanoparticulate glucocorticosteroid formulations
10/08/2008EP1976533A2 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases
10/08/2008EP1976532A2 Fast acting inhibitor of gastric acid secretion
10/08/2008EP1976531A1 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
10/08/2008EP1976530A1 Combination of mtor inhibitor and antipolate compound
10/08/2008EP1976529A2 Ang2 and vegf inhibitor combinations
10/08/2008EP1976528A2 Prokineticin 2 receptor antagonists
10/08/2008EP1976527A2 Fused triazole tachykinin receptor antagonists
10/08/2008EP1976526A2 Methods and compositions for treating prostate cancer
10/08/2008EP1976525A2 Piperidine and piperazine derivatives
10/08/2008EP1976524A1 Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts
10/08/2008EP1976523A2 Inhibitors of checkpoint kinases
10/08/2008EP1976522A1 Pharmaceutical composition containing montelukast
10/08/2008EP1976521A2 Sublingual fentanyl spray
10/08/2008EP1976520A2 Kit comprising an osmotic laxative and a stimulant laxative for preparing the colon for virtual colonoscopy
10/08/2008EP1976519A2 Cytisine and acetylcholine analogs and methods of treating mood disorders
10/08/2008EP1976518A1 Methods and compositions for treating schizophrenia
10/08/2008EP1976517A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors
10/08/2008EP1976516A2 Viral hepatitis treatment
10/08/2008EP1976515A2 Combination therapy with parp inhibitors
10/08/2008EP1976514A2 Neuronal nicotinic receptor ligands and their use
10/08/2008EP1976513A2 Cycloalkylamines as monoamine reuptake inhibitors
10/08/2008EP1976512A1 Novel thiophene derivatives as s1p1/edg1 receptor agonists
10/08/2008EP1976511A2 Fluorinated arylamide derivatives
10/08/2008EP1976510A2 Compounds for the treatment of metabolic disorders
10/08/2008EP1976509A2 Ppar modulators
10/08/2008EP1976508A2 Flavonoids isolated from oroxylum indicum for treatment of gastrointestinal toxicity, associated symptoms and ulcers
10/08/2008EP1976507A2 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of epilepsy
10/08/2008EP1976506A1 Cannabinoid-containing plant extracts as neuroprotective agents
10/08/2008EP1976505A1 Combretastatin derivatives and related therapeutic methods
10/08/2008EP1976504A2 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
10/08/2008EP1976503A2 Gastric retentive gabapentin dosage forms and methods for using same
10/08/2008EP1976502A1 Small molecule inhibitors of pdz interactions
10/08/2008EP1976501A1 Compositions and methods for preventing or treating inflammatory bowel disease
10/08/2008EP1976500A1 Combination of triazine derivatives and ppar agonists
10/08/2008EP1976499A1 Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases
1 ... 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 ... 7860